Mandatory notification of trade and disclosure of large shareholding
25. Aug 2021 |
2 min read
Vatne Equity AS, a closely related party of Runar Vatne, Board Member of Gentian Diagnostics ASA, has today purchased 100,000 shares in Gentian Diagnostics ASA at a price of NOK 67.2174 per share. After the transaction Vatne Equity AS and closely related parties of Runar Vatne owns 2,337,224 shares Gentian Diagnostics ASA corresponding to 15.17% of the outstanding shares and voting rights.
This information is subject to the disclosure requirements pursuant to MAR and Section 5-12 of the Norwegian Securities Trading Act and the Norwegian Securities Trading Act 4-2 as regards to the disclosure of large shareholding.